Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide + Poractant Alfa for BPD Prevention
NCT03521063Phase 4Unknown
- Sponsor
- Hospital Central Dr. Ignacio Morones Prieto
- Start
- Jan 2018
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of budesonide in bronchopulmonary dysplasia (BPD), sponsored by Hospital Central Dr. Ignacio Morones Prieto. Status: unknown.
02
Drugs
budesonide
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT03521063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03521063.